Related Experiment Video
Updated: Sep 23, 2025

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Determination of WWOX Function in Modulating Cellular Pathways Activated by AP-2α and AP-2γ Transcription Factors in
Damian Kołat1, Żaneta Kałuzińska1, Andrzej K Bednarek1
1Department of Molecular Carcinogenesis, Medical University of Lodz, 90-752 Lodz, Poland.
Abstract:
Following the invention of high-throughput sequencing, cancer research focused on investigating disease-related alterations, often inadvertently omitting tumor heterogeneity. This research was intended to limit the impact of heterogeneity on conclusions related to WWOX/AP-2α/AP-2γ in bladder cancer which differently influenced carcinogenesis. The study examined the signaling pathways regulated by WWOX-dependent AP-2 targets in cell lines as biological replicates using high-throughput sequencing. RT-112, HT-1376 and CAL-29 cell lines were subjected to two stable lentiviral transductions. Following CAGE-seq and differential expression analysis, the most important genes were identified and functionally annotated. Western blot was performed to validate the selected observations. The role of genes in biological processes was assessed and networks were visualized. Ultimately, principal component analysis was performed. The studied genes were found to be implicated in MAPK, Wnt, Ras, PI3K-Akt or Rap1 signaling. Data from pathways were collected, explaining the differences/similarities between phenotypes. FGFR3, STAT6, EFNA1, GSK3B, PIK3CB and SOS1 were successfully validated at the protein level. Afterwards, a definitive network was built using 173 genes. Principal component analysis revealed that the various expression of these genes explains the phenotypes. In conclusion, the current study certified that the signaling pathways regulated by WWOX and AP-2α have more in common than that regulated by AP-2γ. This is because WWOX acts as an EMT inhibitor, AP-2γ as an EMT enhancer while AP-2α as a MET inducer. Therefore, the relevance of AP-2γ in targeted therapy is now more evident. Some of the differently regulated genes can find application in bladder cancer treatment.
Insights
This study reveals WWOX and AP-2α signaling pathways are more similar than AP-2γ in bladder cancer. AP-2γ shows relevance for targeted therapy, with potential applications for differently regulated genes in bladder cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- High-throughput sequencing advanced cancer research but often overlooked tumor heterogeneity.
- Understanding WWOX/AP-2α/AP-2γ roles in bladder cancer is crucial, as they influence carcinogenesis differently.
- This study addresses tumor heterogeneity's impact on WWOX, AP-2α, and AP-2γ in bladder cancer.
Purpose of the Study:
- To investigate signaling pathways regulated by WWOX-dependent AP-2 targets in bladder cancer cell lines.
- To identify and functionally annotate key genes involved in these pathways.
- To elucidate the distinct roles of WWOX, AP-2α, and AP-2γ in bladder cancer progression and their therapeutic relevance.
Main Methods:
- Utilized high-throughput sequencing (CAGE-seq) on bladder cancer cell lines (RT-112, HT-1376, CAL-29) with lentiviral transduction.
- Performed differential gene expression analysis, functional annotation, and network visualization.
- Validated key gene expressions at the protein level using Western blot and analyzed pathway data.
Main Results:
- Identified genes implicated in MAPK, Wnt, Ras, PI3K-Akt, and Rap1 signaling pathways.
- Confirmed differential roles: WWOX as an EMT inhibitor, AP-2γ as an EMT enhancer, and AP-2α as a MET inducer.
- Validated FGFR3, STAT6, EFNA1, GSK3B, PIK3CB, and SOS1 at the protein level; PCA explained phenotypic differences by gene expression.
Conclusions:
- Signaling pathways regulated by WWOX and AP-2α share more similarities than those regulated by AP-2γ in bladder cancer.
- The distinct roles in epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET) highlight AP-2γ's relevance in targeted therapy.
- Differentially regulated genes present potential therapeutic applications for bladder cancer treatment.
More Related Videos
07:34The Power of Simplicity: Sea Urchin Embryos as in Vivo Developmental Models for Studying Complex Cell-to-cell Signaling Network Interactions
Published on: February 16, 2017
09:58An Optimized Protocol for Electrophoretic Mobility Shift Assay Using Infrared Fluorescent Dye-labeled Oligonucleotides
Published on: November 29, 2016
Related Concept Videos
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Master Transcription Regulators
mTOR Signaling and Cancer Progression
The mTOR pathway or the...